A shift by media companies to direct-to-consumer streaming platforms to offset losses from consumers cutting the cord could take time with many unprofitable for a number of years.
RBC Capital Markets initiated coverage on Alpine Immune Sciences Inc (NASDAQ: ALPN), noting that the autoimmune disease market (over $165 billion) is meaningful for the company's lead candidate - povetacicept
Shares of First Citizens BancShares Inc (Delaware) (NASDAQ: FCNCA) were climbing on Thursday.
The company has grown by 400% over the last 18 months, with the acquisitions of CIT Group and the failed Silicon Valley Bank, according to Wedbush.